Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Statement der ExpertInnengruppe „Interstitielle Lungenerkrankungen und Orphan Diseases“ der Österreichischen Gesellschaft für Pneumologie zum Update der internationalen multidisziplinären Klassifikation der interstitiellen Pneumonien 2025

  • David Lang*
  • , Mathis Hochrainer
  • , Kaveh Akbari
  • , Luka Brcic
  • , Klaus Hackner
  • , Tjasa Kamenski-Rathmanner
  • , Dagmar Krenbek
  • , Drolaiz Liu
  • , Patricia Marta
  • , Anna Mayr
  • , Felicitas Oberndorfer
  • , Helmut Prosch
  • , Marijan Puseljic
  • , Georg Sterniste
  • , Michael Studnicka
  • , Gerlig Widmann
  • , Mirja M Wirtz
  • , Markus Zwilak
  • , Nikolaus Kneidinger
  • *Korrespondierende:r Autor:in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift

Abstract

The update of the American Thoracic Society/European Respiratory Society (ATS/ERS) classification of interstitial pneumonias published in 2025 extends the oprior classification system beyond merely idiopathic entities, now also encompassing entities with identifiable triggers [1]. The core component of this update is the terminological reorientation of the classification towards a descriptive, primarily morphologically oriented concept with the aim of a clear differentiation of radiological and histological patterns from clinically defined diseases. Acute interstitial pneumonia (AIP) is now designated as idiopathic diffuse alveolar damage (DAD), and desquamative interstitial pneumonia (DIP) as alveolar macrophage pneumonia (AMP). The pattern of bronchiolocentric interstitial pneumonia (BIP) has been introduced as an independent morphological pattern, reserving the term hypersensitivity pneumonitis (HP) exclusively for multidisciplinary diagnosis in the future. Furthermore, the updated classification provides a biologically founded and clinically applicable categorization system of interstitial and alveolar filling patterns and the prognostically relevant separation into fibrotic and nonfibrotic phenotypes. Also, there is a stronger emphasis on the transparent reporting of the diagnostic confidence by interstitial lung disease (ILD) boards, including the use of "provisional" diagnoses or of the term "unclassifiable ILD" in cases of low and very low diagnostic certainty. The current classification can help to standardize the diagnostic course and to make the decision-making process in the ILD board more transparent. It is to be expected that this update will be the foundation for future research and for new knowledge in the field of ILD. In addition, it should however not be ignored that the new classification has been critisized by some experts with respect to the introduction of the pattern of BIP and the provisional entity of "idiopathic BIP". It is feared that this change in terminology emphasizing the morphological pattern rather than causative factors could lead to reduced attention concerning potential trigger exposures in the diagnostic process.

Titel in ÜbersetzungStatement of the Austrian Society of Pneumology expert group for interstitial lung diseases and orphan diseases on the 2025 update of the international multidisciplinary classification of interstitial pneumonias
OriginalspracheDeutsch
Seiten (von - bis)713-720
Seitenumfang8
FachzeitschriftWiener Klinische Wochenschrift
Jahrgang138
AusgabenummerSuppl 9
Frühes Online-Datum15 Juli 2026
DOIs
PublikationsstatusVeröffentlicht - Juli 2026

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gute Gesundheit und Wohlergehen
    SDG 3 – Gute Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Statement der ExpertInnengruppe „Interstitielle Lungenerkrankungen und Orphan Diseases“ der Österreichischen Gesellschaft für Pneumologie zum Update der internationalen multidisziplinären Klassifikation der interstitiellen Pneumonien 2025“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren